Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy
NCT03658551 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2022-04-06
Summary
The CEDIP LCI study is intended to show the difference in intestinal permeability between compensated and decompensated liver cirrhosis by confocal endoscopy.
Conditions
- Cirrhosis, Liver
Interventions
- DIAGNOSTIC_TEST
-
Fluorescein
Measurement of intensity in the gastrointestinal mucosa after intravenous administration of fluorescein by confocal endoscopy
Sponsors & Collaborators
-
Johannes Gutenberg University Mainz
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-01
- Primary Completion
- 2020-08-01
- Completion
- 2020-08-01
Countries
- Germany
Study Locations
More Related Trials
-
Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis
NCT07031843 ·Status: RECRUITING
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Functional MRI to Determine Severity of Cirrhosis
NCT03623360 ·Status: UNKNOWN
-
Risk Factors and Impact MASLD in Patients With IBD
NCT06328452 ·Status: NOT_YET_RECRUITING
-
Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
NCT01600105 ·Status: COMPLETED ·Phase: PHASE4
-
Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes
NCT06456970 ·Status: NOT_YET_RECRUITING
-
Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients
NCT03539757 ·Status: TERMINATED
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis
NCT01981421 ·Status: UNKNOWN
-
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
NCT05106322 ·Status: RECRUITING
-
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension
NCT03277651 ·Status: UNKNOWN
-
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
NCT06741904 ·Status: ENROLLING_BY_INVITATION
-
Non-invasive Evaluation of Portal Pressure by MRI
NCT02530567 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
NCT05312853 ·Status: NOT_YET_RECRUITING
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
NCT06519162 ·Status: RECRUITING
-
Evaluation of Hepatic Fibrosis on Multiparametric MRI
NCT03085342 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers of Liver Fibrosis
NCT02438917 ·Status: TERMINATED
-
Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
NCT00855907 ·Status: TERMINATED
-
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology
NCT05551884 ·Status: UNKNOWN
-
COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
NCT04329559 ·Status: COMPLETED
-
Electrical Impedance Tomography in Fatty Liver Detection
NCT05189990 ·Status: COMPLETED
-
Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis
NCT02335073 ·Status: COMPLETED
-
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
NCT03492879 ·Status: UNKNOWN ·Phase: NA